Skip to Main Content

3,090

Views

28

CrossRef citations to date

0

Altmetric

Others

Safety and efficacy of verinurad, a selective URAT1 inhibitor, for the treatment of patients with gout and/or asymptomatic hyperuricemia in the United States and Japan: Findings from two phase II trials

David Fitz-PatrickEast-West Medical Research Institute, Honolulu, HI, USA; Correspondence[email protected]
View further author information

,

Kent RobersonDelta Waves Sleep Disorder & Research Center, Colorado Springs, CO, USA; View further author information

,

Kiyoshi NiwaNiwa Family Clinic, Chofu, Tokyo, Japan; View further author information

,

Takabumi FujimuraThinkpark Heart Clinic, Tokyo, Japan; View further author information

,

Koji MoriMori Clinic, Fukuoka, Japan; View further author information

,

Jesse HallArdea Biosciences, Inc., San Diego, CA, USAView further author information

,

Xiaohong YanArdea Biosciences, Inc., San Diego, CA, USAView further author information

,

Zancong ShenArdea Biosciences, Inc., San Diego, CA, USAView further author information

,

Sha LiuArdea Biosciences, Inc., San Diego, CA, USAView further author information

,

Yasushi ItoArdea Biosciences, Inc., San Diego, CA, USAView further author information

&

Scott BaumgartnerArdea Biosciences, Inc., San Diego, CA, USAView further author information